Gromovataya / Shutterstock.com
Does the coming into force of the Nagoya Protocol represent an overdue step in the right direction towards fairness, or more red tape and unattainable expectations? Charles Brabin, a non-practising barrister, sifts through the complexities.
Like gold panners they traverse the world, sifting through matter in the hope of striking lucky and finding immeasurable riches. Yet bioprospectors are more likely to be holding pipettes and sample tubes than metal detectors and pans. Bioprospecting involves searching for elements of the biological world that have potential commercial or scientific value.
The concept of bioprospecting and the issues it raises are not new, but rapid technological advances have brought them to the fore. In October 2014, the Nagoya Protocol of the Convention on Biological Diversity (CBD) came into force with the aim of sharing the benefits of biological wealth. However, the project is still far from completion, critics warn of its flaws and the list of ratifying countries has many gaps, including the US.
So does Nagoya represent an overdue and desperately needed step in the right direction, or more red tape and unattainable expectations?
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
Nagoya Protocol; CBD
